LUNG CANCER 101

234 topics in this forum

1. Both/And, rather than Either/Or: Expert Panel Recommends Ear

   By Guest LCSC Info, March 5, 2012
   • 0 replies
   • 551 views
   • 
   • Guest LCSC Info
   • March 5, 2012

2. My 5 Take Home Msgs from the Santa Monica Targeted Therapies

   By Guest LCSC Info, February 27, 2012
   • 0 replies
   • 523 views
   • 
   • Guest LCSC Info
   • February 27, 2012

3. The Balloon Theory vs. The Puddle Theory

   By Guest LCSC Info, February 17, 2012
   • 0 replies
   • 649 views
   • 
   • Guest LCSC Info
   • February 17, 2012

4. The Right Setting for “Local Therapy”in Advanced Lung Cancer

   By Guest LCSC Info, February 3, 2012
   • 0 replies
   • 622 views
   • 
   • Guest LCSC Info
   • February 3, 2012

5. Concern about Long-Term Recurrences after SBRT

   By Guest LCSC Info, January 30, 2012
   • 0 replies
   • 731 views
   • 
   • Guest LCSC Info
   • January 30, 2012

6. Some New Insights About T790M Mutations & Resistance to Oral

   By Guest LCSC Info, January 23, 2012
   • 0 replies
   • 773 views
   • 
   • Guest LCSC Info
   • January 23, 2012

7. Understanding Resistance to ALK Inhibitor Therapy

   By Guest LCSC Info, January 23, 2012
   • 0 replies
   • 692 views
   • 
   • Guest LCSC Info
   • January 23, 2012

8. ROS1: New Marker of Small Population w/ Apparent Big Benefit

   By Guest LCSC Info, January 10, 2012
   • 0 replies
   • 756 views
   • 
   • Guest LCSC Info
   • January 10, 2012

9. HER2/neu: Another Uncommon & Potentially Important Therapeut

   By Guest LCSC Info, January 10, 2012
   • 0 replies
   • 771 views
   • 
   • Guest LCSC Info
   • January 10, 2012

10. Continuation Maintenance Therapy with Alimta/Avastin

    By Guest LCSC Info, January 10, 2012
    • 0 replies
    • 769 views
    • 
    • Guest LCSC Info
    • January 10, 2012

11. Acquired Resistance to EGFR Tyrosine Kinase Inhibitor Therap

    By Guest LCSC Info, January 10, 2012
    • 0 replies
    • 744 views
    • 
    • Guest LCSC Info
    • January 10, 2012

12. Evaluating & Managing Lung Nodules, by Dr. David Yankelevitz

    By Guest LCSC Info, January 10, 2012
    • 0 replies
    • 697 views
    • 
    • Guest LCSC Info
    • January 10, 2012

13. Pre-Operative (Neoadjuvant) Chemo for Resectable NSCLC

    By Guest LCSC Info, January 10, 2012
    • 0 replies
    • 673 views
    • 
    • Guest LCSC Info
    • January 10, 2012

14. CT Screening’s Cost-Effectiveness/Importance of Smoking Cess

    By Guest LCSC Info, January 10, 2012
    • 0 replies
    • 746 views
    • 
    • Guest LCSC Info
    • January 10, 2012

15. Second Opinions: Who, What, Where, When, Why, and How?

    By Guest LCSC Info, January 10, 2012
    • 0 replies
    • 771 views
    • 
    • Guest LCSC Info
    • January 10, 2012

16. Dr. Ross Camidge on ALK Inhibitor XALKORI, Who To Screen

    By Guest LCSC Info, January 10, 2012
    • 0 replies
    • 568 views
    • 
    • Guest LCSC Info
    • January 10, 2012

17. Is there a value in quitting smoking after diagnosis?

    By Guest LCSC Info, January 10, 2012
    • 0 replies
    • 619 views
    • 
    • Guest LCSC Info
    • January 10, 2012

18. Podcast/Dr. Ben Solomon, ALK Inhibition, from Science to FDA

    By Guest LCSC Info, January 10, 2012
    • 0 replies
    • 519 views
    • 
    • Guest LCSC Info
    • January 10, 2012

19. Afatinib’s activity in advanced NSCLC: A glass half empty or

    By Guest LCSC Info, January 10, 2012
    • 0 replies
    • 580 views
    • 
    • Guest LCSC Info
    • January 10, 2012

20. Clinical Relevance of Occult Metastases in Lymph Nodes

    By Guest LCSC Info, January 10, 2012
    • 0 replies
    • 562 views
    • 
    • Guest LCSC Info
    • January 10, 2012

21. Complexities of Managing Lung Cancer in the Elderly: Webinar

    By Guest LCSC Info, January 10, 2012
    • 0 replies
    • 538 views
    • 
    • Guest LCSC Info
    • January 10, 2012

22. Keeping it Old School: Escalation of Chest RT Dose Fails

    By Guest LCSC Info, January 10, 2012
    • 0 replies
    • 477 views
    • 
    • Guest LCSC Info
    • January 10, 2012

23. Podcast: Special Considerations of Managing LC in Elderly

    By Guest LCSC Info, January 10, 2012
    • 0 replies
    • 489 views
    • 
    • Guest LCSC Info
    • January 10, 2012

24. Alimta/Avastin Combo as Maintenance Therapy

    By Guest LCSC Info, January 10, 2012
    • 0 replies
    • 559 views
    • 
    • Guest LCSC Info
    • January 10, 2012

25. Q&A: Dr. Lacouture, Derm Side Effects of Cancer Treatment

    By Guest LCSC Info, January 10, 2012
    • 0 replies
    • 474 views
    • 
    • Guest LCSC Info
    • January 10, 2012